MedTrace Logo

Recombinant Factor VII for Intractable Postpartum Haemorrhage

NCT05298826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2022-03-28

No results posted yet for this study

Summary

Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .

Conditions

  • Post Partum Hemorrhage

Interventions

DRUG

recombinant factor VIIa

using recombinant factor VIIa

Sponsors & Collaborators

  • Aljazeera Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-01-01
Completion
2020-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05298826 on ClinicalTrials.gov